User login
Educational interventions improve outcomes for children with asthma
Asthma education interventions for children may result in modest improvement in a wide range of clinical outcomes. Interventions should target children with more severe asthma and teach them to use objective measures of lung function, such as peak flow for self-monitoring instead of symptombased self-monitoring.
Asthma education interventions for children may result in modest improvement in a wide range of clinical outcomes. Interventions should target children with more severe asthma and teach them to use objective measures of lung function, such as peak flow for self-monitoring instead of symptombased self-monitoring.
Asthma education interventions for children may result in modest improvement in a wide range of clinical outcomes. Interventions should target children with more severe asthma and teach them to use objective measures of lung function, such as peak flow for self-monitoring instead of symptombased self-monitoring.
Estrogen plus progestin may increase incidence of dementia
Estrogen plus progestin does not decrease— and may actually increase—the incidence of dementia, mild cognitive impairment, and cognitive dysfunction in elderly postmenopausal women. The effect of unopposed estrogen on these outcomes is still unknown. With these new findings and the recently reported results of the Women’s Health Initiative, for most women the benefits of estrogen plus progestin do not outweigh the risks.
Estrogen plus progestin does not decrease— and may actually increase—the incidence of dementia, mild cognitive impairment, and cognitive dysfunction in elderly postmenopausal women. The effect of unopposed estrogen on these outcomes is still unknown. With these new findings and the recently reported results of the Women’s Health Initiative, for most women the benefits of estrogen plus progestin do not outweigh the risks.
Estrogen plus progestin does not decrease— and may actually increase—the incidence of dementia, mild cognitive impairment, and cognitive dysfunction in elderly postmenopausal women. The effect of unopposed estrogen on these outcomes is still unknown. With these new findings and the recently reported results of the Women’s Health Initiative, for most women the benefits of estrogen plus progestin do not outweigh the risks.
Cervical spondylotic myelopathy: Make the difficult diagnosis, then refer for surgery
Hair Care Practices in African American Women
Prevention of Cross-Contamination When Using Microdermabrasion Equipment
Navigating the Management of Hepatitis C
Supplement Editor:
William Carey, MD
Contents
The epidemiology and natural history of hepatitis C virus infection
Nizar N. Zein, MD
Tests and screening strategies for the diagnosis of hepatitis C
William Carey, MD
Management of newly diagnosed hepatitis C virus infection
Mark W. Russo, MD, MPH; Steven L. Zacks, MD, MPH; and Michael W. Fried, MD
Treatment options for nonresponders and relapsers to initial therapy for hepatitis C
Marten Duncan, DO, and Zobair Younossi, MD, MPH
Special management challenges in hepatitis C
Jose Martagon, MD, and Steven M. Gordon, MD
Supplement Editor:
William Carey, MD
Contents
The epidemiology and natural history of hepatitis C virus infection
Nizar N. Zein, MD
Tests and screening strategies for the diagnosis of hepatitis C
William Carey, MD
Management of newly diagnosed hepatitis C virus infection
Mark W. Russo, MD, MPH; Steven L. Zacks, MD, MPH; and Michael W. Fried, MD
Treatment options for nonresponders and relapsers to initial therapy for hepatitis C
Marten Duncan, DO, and Zobair Younossi, MD, MPH
Special management challenges in hepatitis C
Jose Martagon, MD, and Steven M. Gordon, MD
Supplement Editor:
William Carey, MD
Contents
The epidemiology and natural history of hepatitis C virus infection
Nizar N. Zein, MD
Tests and screening strategies for the diagnosis of hepatitis C
William Carey, MD
Management of newly diagnosed hepatitis C virus infection
Mark W. Russo, MD, MPH; Steven L. Zacks, MD, MPH; and Michael W. Fried, MD
Treatment options for nonresponders and relapsers to initial therapy for hepatitis C
Marten Duncan, DO, and Zobair Younossi, MD, MPH
Special management challenges in hepatitis C
Jose Martagon, MD, and Steven M. Gordon, MD
Anticholinergics reduce symptoms of overactive bladder
Anticholinergic drugs such as tolterodine and oxybutynin produce a small effect on the symptoms of overactive bladder, decreasing slightly the number of episodes of leakage and the frequency of urination. The standard conservative intervention of bladder retraining has not been compared with anticholinergic drugs and their effect in combination has not been studied.
Anticholinergic drugs such as tolterodine and oxybutynin produce a small effect on the symptoms of overactive bladder, decreasing slightly the number of episodes of leakage and the frequency of urination. The standard conservative intervention of bladder retraining has not been compared with anticholinergic drugs and their effect in combination has not been studied.
Anticholinergic drugs such as tolterodine and oxybutynin produce a small effect on the symptoms of overactive bladder, decreasing slightly the number of episodes of leakage and the frequency of urination. The standard conservative intervention of bladder retraining has not been compared with anticholinergic drugs and their effect in combination has not been studied.